Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
Grazia Lazzari,1 Giuseppe Buono,2 Benedetto Zannino,2 Giovanni Silvano1 1Radiation Oncology Unit, San Giuseppe Moscati Hospital, Taranto, 74100, Italy; 2Medical Oncology Unit, San Rocco Hospital, Sessa Aurunca, Caserta, 81037, ItalyCorrespondence: Grazia LazzariRadiation Oncology Unit, San Giuseppe...
Guardado en:
Autores principales: | Lazzari G, Buono G, Zannino B, Silvano G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb58ab0776f14abcbf70ba335c8c3fa1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutación del gen p53 en el cáncer de la vesícula biliar
por: Roa E,Iván, et al.
Publicado: (2000) -
Single nucleotide polymorphisms and unacceptable late toxicity in breast cancer adjuvant radiotherapy: a case report
por: Lazzari G, et al.
Publicado: (2017) -
The antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cells
por: Crone M, et al.
Publicado: (2019) -
Monte Carlo Evaluation of Dose Enhancement Due to CuATSM or GNP Uptake in Hypoxic Environments with External Beam Radiation
por: Martinez S, et al.
Publicado: (2020) -
3D Breast Tumor Models for Radiobiology Applications
por: Akhilandeshwari Ravichandran, et al.
Publicado: (2021)